34 Best Deep Tech Startups in Cambridge to Watch in 2025

The Definitive Seedtable Ranking of Deep Tech Startups in Cambridge

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 34 start-ups with an aggregate funding of $2.1b. The average funding per company in this subset is $61.2m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

4

Funding Rounds

$49.3m

Money raised

Sphere Fluidics is a company commercializing single cell analysis systems founded in 2010 by Wilhelm Huck.

3

Funding Rounds

$183.9m

Money raised

Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.

3

Funding Rounds

$133.0m

Money raised

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Key people:

5

Funding Rounds

$30.9m

Money raised

Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services

Key people:

6

Funding Rounds

$2.4m

Money raised

A company that has developed software for easier access to genomic data. It is located in Cambridge, England and was founded in 2015.

Key people:

8

Funding Rounds

$84.5m

Money raised

Mogrify is developing tailored cellular conversions that power future cell therapies.

13

Funding Rounds

$123.5m

Money raised

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.

4

Funding Rounds

$420.2m

Money raised

Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells

1

Funding Rounds

$24.0m

Money raised

Ieso Digital Health is a Cambridge, Cambridgeshire-based digital health company offering internet enabled evidence-based psychological therapies.

4

Funding Rounds

$76.8m

Money raised

Provider of SITESEEKER platform for discovering new drugs.

5

Funding Rounds

$10.5m

Money raised

Definigen is a human Cell Models of Rare Diseases founded in 2012 by Marcus Yeo.

3

Funding Rounds

$77.0m

Money raised

PetMedix is a veterinary therapeutics biotechnology company based in Cambridge, UK. working to develop precision therapeutics to improve the health and welfare of pets.

3

Funding Rounds

$115.0m

Money raised

Platform for AI-driven drug discovery in clinical-stage development.

Key people:

4

Funding Rounds

$101.6m

Money raised

Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer

4

Funding Rounds

$166.8m

Money raised

Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.

1

Funding Rounds

$40.6m

Money raised

Therapies designed to achieve long-term disease remission with less frequent doses.

2

Funding Rounds

$20.7m

Money raised

FiveAI is an artificial Intelligence company founded in 2015 by John Redford.

10

Funding Rounds

$27.8m

Money raised

A Cambridge UK based company focused on the development of technologies for single-molecule analysis

Key people:

4

Funding Rounds

$58.3m

Money raised

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

2

Funding Rounds

$62.0m

Money raised

Fluidic Analytics is a tools that revolutionize how proteins are characterized founded in 2013 by Tuomas Knowles.

2

Funding Rounds

$8.2m

Money raised

CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.

Key people:

2

Funding Rounds

$19.1m

Money raised

PredictImmune is a Cambridge, Cambridgeshire-based medical diagnostics company developing diagnostic products for addressing inflammatory bowel diseases.

1

Funding Rounds

$88.0m

Money raised

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

Key people:

4

Funding Rounds

$23.2m

Money raised

Platform for increasing protein production in the body using specialized translation enhancers.

1

Funding Rounds

$22.4m

Money raised

Cancer diagnostics.

2

Funding Rounds

$7.5m

Money raised

Contract Research Organization specializing in bioscience research services.

4

Funding Rounds

$48.0m

Money raised

Supplier of configurable process node agnostic analog IP building blocks.

1

Funding Rounds

$2.3m

Money raised

PharmEnable is an AI Drug Discovery platform founded in 2016.

1

Funding Rounds

$5.3m

Money raised

Platform that enhances images by using patented Image Fusion technology and Deep Learning to reveal more color, detail, and clarity.

2

Funding Rounds

$7.2m

Money raised

Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications.

2

Funding Rounds

$33.5m

Money raised

Acacia Pharma is a small Molecules founded in 2006.

1

Funding Rounds

$1.3m

Money raised

Platform developing innovative drugs for cancer treatment.

1

Funding Rounds

$1.6m

Money raised

Solascure Limited is a treatment for patients with chronic wounds founded in 2017.

1

Funding Rounds

$3.0m

Money raised

Supplant is a "Biotechnology platform producing sugar substitutes.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.